2021
DOI: 10.1136/annrheumdis-2021-220089
|View full text |Cite
|
Sign up to set email alerts
|

Pathogenic UBA1 variants associated with VEXAS syndrome in Japanese patients with relapsing polychondritis

Abstract: ObjectivesTo determine clinical and genetic features of individuals with relapsing polychondritis (RP) likely caused by pathogenic somatic variants in ubiquitin-like modifier activating enzyme 1 (UBA1).MethodsFourteen patients with RP who met the Damiani and Levine criteria were recruited (12 men, 2 women; median onset age (IQR) 72.1 years (67.1–78.0)). Sanger sequencing of UBA1 was performed using genomic DNA from peripheral blood leukocytes or bone marrow tissue. Droplet digital PCR (ddPCR) and peptide nucle… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
82
1
8

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 112 publications
(92 citation statements)
references
References 21 publications
1
82
1
8
Order By: Relevance
“…VEXAS (Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome [1] is described as a late-onset autoinflammatory syndrome exhibiting a spectrum of systemic inflammatory manifestations as well as significant haematologic abnormalities such as macrocytic anaemia, marrow dysplasia, vacuolisation in myeloid cells [2] and thrombosis. Several published case series [1,[3][4][5][6][7][8][9][10] have observed a high prevalence of venous thromboembolism (VTE) in patients with VEXAS syndrome of between 10% and 56%, with a significant mortality rate (27%-50%). We report a case of VEXAS syndrome complicated by unprovoked venous thromboembolism, followed by a rapid review of available literature.…”
Section: Introductionmentioning
confidence: 99%
“…VEXAS (Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome [1] is described as a late-onset autoinflammatory syndrome exhibiting a spectrum of systemic inflammatory manifestations as well as significant haematologic abnormalities such as macrocytic anaemia, marrow dysplasia, vacuolisation in myeloid cells [2] and thrombosis. Several published case series [1,[3][4][5][6][7][8][9][10] have observed a high prevalence of venous thromboembolism (VTE) in patients with VEXAS syndrome of between 10% and 56%, with a significant mortality rate (27%-50%). We report a case of VEXAS syndrome complicated by unprovoked venous thromboembolism, followed by a rapid review of available literature.…”
Section: Introductionmentioning
confidence: 99%
“…The condition was named VEXAS syndrome (15). Interestingly, Japanese patients with UBA1 gene mutations also have a high prevalence of myelodysplastic syndromes (16). Further studies are required to investigate the prevalence of the mutation of UBA1 gene in the general population among different ethnic groups.…”
Section: Discussionmentioning
confidence: 99%
“…UBA1 mutation has been recently described in a female patient, but in this case, variant allele frequency was very low (0,14%) and no cytogenetic analysis was performed. 3 Our case shows that, as the UBA1 gene is located on the X chromosome, VEXAS syndrome may also be observed in women with monosomy X. Therefore, in an unexplained inflammatory syndrome, screening of UBA1 mutation is required not only in men but also in women with typical vacuoles in myeloid precursors and monosomy X (Figure 1).…”
mentioning
confidence: 80%